Genkyotex Provides Business Update and Reports Cash Position at June 30, 2020
(WorldNews Denmark)

Genkyotex Provides Business Update and Reports Cash Position at June 30, 2020 23 Jul 2020 18:00 CEST Company Name GENKYOTEX ISN FR0013399474 Market Euronext Symbol GKTX Cash and cash equivalents of €5.1 million as of June 30, 2020 Ongoing discussions with US FDA and European EMA on the registration strategy for setanaxib in PBC Phase 1 study with high-dose setanaxib launched in June Launch of the Phase 2 IPF trial still expected in 2020 despite the COVID-19 situation Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX)(Euronext Paris & Brussels: FR0013399474 - GKTX), a biopharmaceutical company and the leader in NOX therapies, today reported cash and cash equivalents of €5.1 million as of...